← Leaderboards
Jennifer J Hu
Wake Forest University
$7,032,605
Attributed
$7,768,345
Total exposure
12
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $700K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,768,345 · 12
By mechanism
R01$4,904,866 · 3
U01$1,471,480 · 1
R21$697,666 · 2
R03$369,962 · 2
R29$252,656 · 1
P30$53,375 · 1
Top collaborators
- Yan Wang3 shared
Others in their field
Top investigators on “Dna Repair”
- John A Tainer · Scripps Research Institute$45,990,082
- Aziz Sancar · University Of North Carolina Chapel Hill$30,640,499
- Patrick Sung · University Of Texas Hlth Sci Ctr San Ant$30,442,761
- John M Essigmann · Massachusetts Institute Of Technology$27,654,594
- Loic Le Marchand · University Of Hawaii At Manoa$26,643,180
- Maria Jasin · Sloan-Kettering Institute For Cancer Res$25,953,946
Research focus
Dna RepairCancer RiskFundingClinical ResearchAdverse ReactionsHuman SubjectResponseQuality Of LifeAfrican AmericanPositioning AttributeMalignant Breast NeoplasmMinorityEpidemiologistDna DamageWomanBreastNeoplasm /Cancer GeneticsRadiation ToleranceCessation Of LifeInflammationLate EffectsCancer DiagnosisAmericanCancer Etiology
Grant awards (44)
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments$190,116
U01 · FY2025 · CA · contact PI
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments$617,738
U01 · FY2024 · CA · contact PI
Assessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After Treatments$663,626
U01 · FY2023 · CA · contact PI
Metabolomics: Novel Strategies to Improve Breast Cancer Radiotherapy Responses$208,454
R21 · FY2020 · CA · contact PI
Metabolomics: Novel Strategies to Improve Breast Cancer Radiotherapy Responses$39,508
R21 · FY2020 · CA · contact PI
Metabolomics: Novel Strategies to Improve Breast Cancer Radiotherapy Responses$233,704
R21 · FY2019 · CA · contact PI
Immune and Inflammatory Biomarkers in Radiotherapy-Induced Skin Toxicities$76,750
R03 · FY2016 · CA · contact PI
Immune and Inflammatory Biomarkers in Radiotherapy-Induced Skin Toxicities$3,991
R03 · FY2016 · CA · contact PI
Immune and Inflammatory Biomarkers in Radiotherapy-Induced Skin Toxicities$76,750
R03 · FY2015 · CA · contact PI
Immune and Inflammatory Biomarkers in Radiotherapy-Induced Skin Toxicities$67,908
R03 · FY2015 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$506,765
R01 · FY2014 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$497,121
R01 · FY2013 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$408,383
R01 · FY2012 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$558,964
R01 · FY2011 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$140,990
R01 · FY2011 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$610,077
R01 · FY2010 · CA · contact PI
Impact of Genomics on Disparities in Breast Cancer Radiosensitivity$69,488
R01 · FY2010 · CA · contact PI
Molecular Epidemiology and Prevention of Breast Cancer$121,760
R01 · FY2007 · CA · contact PI
Molecular Epidemiology and Prevention of Breast Cancer$257,216
R01 · FY2006 · CA · contact PI
Molecular Epidemiology and Prevention of Breast Cancer$69,225
R01 · FY2006 · CA · contact PI
Molecular Epidemiology and Prevention of Breast Cancer$286,024
R01 · FY2005 · CA
Molecular Genetics of Colon Cancer in Blacks and Whites$181,169
R01 · FY2005 · CA
Molecular Genetics of Colon Cancer in Blacks and Whites$51,564
R01 · FY2005 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$13,962
M01 · FY2005 · RR
Molecular Epidemiology and Prevention of Breast Cancer$281,710
R01 · FY2004 · CA
Molecular Genetics of Colon Cancer in Blacks and Whites$121,355
R01 · FY2004 · CA
Molecular Epidemiology and Prevention of Breast Cancer$5,649
R01 · FY2004 · CA
Molecular Epidemiology of Prostate Cancer$4,378
M01 · FY2004 · RR
Molecular Epidemiology and Prevention of Breast Cancer$288,193
R01 · FY2003 · CA
EFFECTS OF FRUIT &VEGETABLE EXTRACTS ON CANCER MARKERS$216,000
R21 · FY2003 · CA
Molecular Genetics of Colon Cancer in Blacks and Whites$207,762
R01 · FY2003 · CA
Molecular Genetics of Colon Cancer in Blacks and Whites$241,451
R01 · FY2002 · CA
DNA REPAIR GENOTYPE AND PHENOTYPE IN BREAST CANCER RISK$72,250
R03 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$0
P30 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$0
P30 · FY2002 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$0
M01 · FY2002 · RR
MOLECULAR EPIDEMIOLOGY AND PREVENTION OF BREAST CANCER$93,837
R29 · FY2001 · CA
DNA REPAIR GENOTYPE AND PHENOTYPE IN BREAST CANCER RISK$72,313
R03 · FY2001 · CA
CORE--DEVELOPMENTAL FUNDS$53,375
P30 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY AND PREVENTION OF BREAST CANCER$29,678
R29 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY AND PREVENTION OF BREAST CANCER$22,711
R29 · FY2001 · CA
CORE--DEVELOPMENTAL FUNDS$0
P30 · FY2001 · CA
MOLECULAR EPIDEMIOLOGY AND PREVENTION OF BREAST CANCER$106,430
R29 · FY2000 · CA
MOLECULAR EPIDEMIOLOGY OF PROSTATE CANCER$0
M01 · FY2000 · RR